بعض من الأوراق البحثية المتاحة حول - TopicsExpress



          

بعض من الأوراق البحثية المتاحة حول الإلتهابات , العدوى , المناعة , الخلية , السرطان ...إلخ Grivennikov, S. I., Greten, F. R. & Karin, M.. Immunity, inflammation, and cancer. ac.els-cdn/S0092867410000607/1-s2.0-S0092867410000607-main.pdf?_tid=45ab1fb4-1bb3-11e3-b701-00000aab0f6b&acdnat=1378994433_eebdfa049bfc80f1ec7871ddab07f4f7 .. Leichtle, A., Lai, Y., Wollenberg, B., Wasserman, S. I. & Ryan, A. F.. Innate signaling in otitis media: pathogenesis and recovery. Curr. Allergy Asthma Rep link.springer/content/pdf/10.1007%2Fs11882-010-0158-3.pdf .... Nathan, C. & Ding, A.. Nonresolving inflammation. Cell ac.els-cdn/S0092867410001820/1-s2.0-S0092867410001820-main.pdf?_tid=cd9d824a-1bb3-11e3-8be7-00000aab0f01&acdnat=1378994661_187b67a88a6d7cd0cdf1f9c1d2b17df4 .... Niederberger, E. & Geisslinger, G.. The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy? FASEB J. 22, 3432–3442 (2008) . fasebj.org/content/22/10/3432.full.pdf+html .... Lim, J. H. et al. CYLD negatively regulates transforming growth factor-beta-signalling via deubiquitinating Akt. Nat. Commun nature/ncomms/journal/v3/n4/full/ncomms1776.html .... Sun, S. C.. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ. 17, 25–34 (2010) . nature/cdd/journal/v17/n1/full/cdd200943a.html …. Jono, H. et al. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J. Biol. Chem. 279,36171–36174 (2004) . jbc.org/content/279/35/36171.full.pdf+html .... Lim, J. H. et al. Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice. PLoS One 2,e1032 (2007) . plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001032&representation=PDF ... Yoshida, H., Jono, H., Kai, H. & Li, J. D.. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J. Biol. Chem. 280, 41111–41121 (2005) . jbc.org/content/280/49/41111.full.pdf+html .... Espinosa, L. et al. The Notch/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia. Cancer Cell 18, 268–281 (2010) . ac.els-cdn/S1535610810003028/1-s2.0-S1535610810003028-main.pdf?_tid=46ba881a-1bb6-11e3-9f42-00000aacb361&acdnat=1378995723_e187ab495077723fc18e5700b93a2a38 .... Lim, J. H. et al. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 27, 349–360 (2007) . ac.els-cdn/S1074761307003743/1-s2.0-S1074761307003743-main.pdf?_tid=73ea7f2a-1bb6-11e3-9606-00000aacb362&acdnat=1378995799_99b366b56fb16a06af7432634e7dae75 .... Bender, A. T. & Beavo, J. A.. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev. 58, 488–520 (2006) . pharmrev.aspetjournals.org/content/58/3/488.full.pdf+html .... Fischmeister, R. et al. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ. Res. 99, 816–828 (2006) . circres.ahajournals.org/content/99/8/816.full.pdf+html .... Nikolaev, V. O., Gambaryan, S., Engelhardt, S., Walter, U. & Lohse, M. J.. Real-time monitoring of the PDE2 activity of live cells: hormone-stimulated cAMP hydrolysis is faster than hormone-stimulated cAMP synthesis. J. Biol. Chem. 280, 1716–1719 (2005) . jbc.org/content/280/3/1716.full.pdf+html .... Banner, K. H. & Press, N. J.. Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease. Br. J. Pharmacol. 157, 892–906 (2009) . onlinelibrary.wiley/doi/10.1111/j.1476-5381.2009.00170.x/pdf .... Jin, S. L., Richard, F. J., Kuo, W. P., D’Ercole, A. J. & Conti, M.. Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. Proc. Natl Acad. Sci. USA 96,11998–12003 (1999) . pnas.org/content/96/21/11998.full.pdf+html .... Barber, R. et al. Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L332–L343 (2004) . ajplung.physiology.org/content/287/2/L332 .... Lee, J. et al. Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway. J. Biol. Chem.287, 22799–22811 (2012) . jbc.org/content/287/27/22799.full.pdf+html .... Ha, U. H. et al. MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway. J. Biol. Chem. 283,30624–30631 (2008) . jbc.org/content/283/45/30624.full.pdf+html ... Barnes, P. J.. The cytokine network in asthma and chronic obstructive pulmonary disease. J. Clin. Invest. 118, 3546–3556 (2008) . jci.org/articles/view/36130 .... Sabapathy, K. et al. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol. Cell 15, 713–725 (2004) . ac.els-cdn/S1097276504005143/1-s2.0-S1097276504005143-main.pdf?_tid=662acd7e-1bb9-11e3-8518-00000aab0f6c&acdnat=1378997064_66d2fed16965d959d43180a433db0837 .... Blonska, M. et al. The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. Immunity 26, 55–66 (2007) . ac.els-cdn/S1074761306005371/1-s2.0-S1074761306005371-main.pdf?_tid=7fcf8a26-1bb9-11e3-9f67-00000aab0f01&acdnat=1378997107_341ff4b3b767c4fad8388efc21f5b058 .... Liu, J., Minemoto, Y. & Lin, A.. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol. Cell Biol. 24, 10844–10856 (2004) . mcb.asm.org/content/24/24/10844.full.pdf+html .... Imasato, A. et al. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J. Biol. Chem. 277, 47444–47450 (2002) . jbc.org/content/277/49/47444.full.pdf+html .... Wang, B. et al. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J. Biol. Chem. 277,949–957 (2002) . jbc.org/content/277/2/949.full.pdf+html .... Sakai, A. et al. The bacterium, nontypeable Haemophilus influenzae, enhances host antiviral response by inducing Toll-like receptor 7 expression: evidence for negative regulation of host anti-viral response by CYLD. FEBS J. 274, 3655–3668 (2007) . onlinelibrary.wiley/doi/10.1111/j.1742-4658.2007.05899.x/pdf .... Jeon, K. I. et al. Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proc. Natl Acad. Sci. USA 107, 9795–9800(2010) . pnas.org/content/107/21/9795.full.pdf+html ........ Xu, X. et al. EVI1 Acts as an inducible negative-feedback regulator of NF-kappaB by inhibiting p65 acetylation. J. Immunol. 188, 6371–6380 (2012) . jimmunol.org/content/188/12/6371.full.pdf+html ....
Posted on: Thu, 12 Sep 2013 20:45:36 +0000

Recently Viewed Topics




© 2015